Esophageal cancer (EC) is a common gastrointestinal malignancy with poor prognosis and
high mortality. Although combined therapeutic strategies have been developed, the 5-year …

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies
worldwide, especially in East Asia. ESCC accounts for more than 90% of esophageal …

Objectives Clinical studies on immune checkpoint inhibitors (ICIs) combined with
neoadjuvant chemotherapy (nCT) have been carried out for the resectable esophageal …

Purpose Neoadjuvant chemoimmunotherapy (nCIT) is becoming a new therapeutic frontier
for resectable esophageal squamous cell carcinoma (ESCC); however, crucial details and …

Objectives: To identify the effective approach between neoadjuvant chemotherapy (NCT)
and chemoradiotherapy (NCRT) by comparing patient survival and complications. Methods …

Background Significant progress has been made in the investigation of neoadjuvant
immune-chemoradiotherapy (NICRT) and neoadjuvant immune-chemotherapy (NICT) on …

Background Dynamic alterations of the tumor immune microenvironment in esophageal
squamous cell carcinoma (ESCC) after different neoadjuvant therapies were understudied …

Objectives To assess volumetric DCE-MRI radiomics nomogram in predicting response to
neoadjuvant chemotherapy (nCT) in EC patients. Methods This retrospective analysis of a …

Simple Summary Multimodal therapy concepts, including surgery and systemic therapy, are
the mainstay in the treatment of esophageal adenocarcinoma. Despite the technical …

Objectives To compare the survival and complications of neoadjuvant chemoradiation
(NCRT) versus neoadjuvant chemotherapy (NCT) for esophageal squamous cell carcinoma …